Publications by authors named "Haifan Xu"

Claim this Profile
T
Treatment beyond progression and rechallenge with pyrotinib in HER2-positive metastatic breast cancer and brain metastases: a multicenter real-world study.
Jing Peng, Qitong Chen, Liping Liu, Ning Xie, Mingwen Liu, Xuan Liu, Haifan Xu, Feng Xu

Ther Adv Med Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin signaling in the regulation of natural killer cells biology in breast cancer.
Jiachi Xu, Hongyu Gao, Muhammad Salman Azhar, Haifan Xu, Siyuan Chen

Front Immunol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and Influencing Factors of Intra-Dialysis Blood Pressure Variability in Hemodialysis Patients: A Retrospective Study.
Haifan Xu, Xiaoshuang Wang, Miao Feng, Liqun Chen

Int J Gen Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artemisinin ameliorates thyroid function and complications in adult male hypothyroid rats via upregulation of the L1 cell adhesion molecule.
Lingling Li, Haifan Xu, Zecheng Hu, Li Li

Thyroid Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning application identifies plasma markers for proteinuria in metastatic colorectal cancer patients treated with Bevacizumab.
Zhuoyuan Yu, Haifan Xu, Miao Feng, Liqun Chen

Cancer Chemother Pharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of roxadustat in maintenance hemodialysis patients with erythropoietin-hyporesponsive anemia.
Xiaoshuang Wang, Hezhou Cai, Haifan Xu, Liqun Chen

Clin Nephrol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study.
Meirong Zhou, Shouman Wang, Nengbin Wan, Songlin Yuan, Xiongqiang Hu, Haifan Xu, Feng Xu

Ann Transl Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the evolution trends and influential factors of bankfull discharge in the Lower Yellow River.
Meng Chen, Linjuan Xu, Chunpeng Xing, Haifan Xu, Wanjie Zhao

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ambrosin sesquiterpene lactone exerts selective and potent anticancer effects in drug-resistant human breast cancer cells (MDA-MB-231) through mitochondrial mediated apoptosis, ROS generation and targeting Akt/β-Catenin signaling pathway.
Shanji Fan, Ying Cui, Zecheng Hu, Wenhao Wang, Wujiu Jiang, Haifan Xu

J BUON· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of glucose-regulated protein 78 as prognostic biomarkers for triple-negative breast cancer.
Chenlian Yang, Zhiwei Zhang, Yutian Zou, Guanfeng Gao, Lingrui Liu, Haifan Xu

Histol Histopathol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of cancer cell growth by Tangeretin flavone in drug-resistant MDA-MB-231 human breast carcinoma cells is facilitated via targeting cell apoptosis, cell cycle phase distribution, cell invasion and activation of numerous Caspases.
Shanji Fan, Haifan Xu, Hongguang Liu, Zecheng Hu, Junyan Xiao

J BUON· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic activity of DCC-2036, a novel tyrosine kinase inhibitor, against triple-negative breast cancer patient-derived xenografts by targeting AXL/MET.
Yingying Shen, Wei Zhang, Jianghua Liu, Jun He, Renxian Cao, Haifan Xu, Xuyu Zu

Int J Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of TXNDC5 in tumorigenesis of colorectal cancer cells: In vivo and in vitro evidence.
Fengbo Tan, Hong Zhu, Xiao He, Nanhui Yu, Xingwen Zhang, Haifan Xu

Int J Mol Med· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum miR-20a is a promising biomarker for gastric cancer.
Ruirui Yang, Yun Fu, Ying Zeng, Mengqin Xiang, Yufang Yin, Haifan Xu

Biomed Rep· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous nuclear ribonucleoprotein K is overexpressed and associated with poor prognosis in gastric cancer.
Ruirui Yang, Ying Zeng, Haifan Xu, Zhuo Chen, Mengqin Xiang

Oncol Rep· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia regulates stemness of breast cancer MDA-MB-231 cells.
Jing Xie, Yong Xiao, Xiao-yan Zhu, Zhou-yu Ning, Hai-fan Xu

Med Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuron navigator 2 overexpression indicates poor prognosis of colorectal cancer and promotes invasion through the SSH1L/cofilin-1 pathway.
Fengbo Tan, Hong Zhu, Yiming Tao, Nanhui Yu, Qian Pei, Haifan Xu

J Exp Clin Cancer Res· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
U6 is not a suitable endogenous control for the quantification of circulating microRNAs.
Mengqin Xiang, Ying Zeng, Ruirui Yang, Haifan Xu, Zhuo Chen, Yinghui Xu

Biochem Biophys Res Commun· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis